Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06970522 · ClinicalTrials.gov registry record
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
A clinical trial of Neuromuscular Disorders and Motor Development, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- 40
- Enrollment target
- 2
- Study locations
NCT06970522: Recruiting study of Neuromuscular Disorders and Motor Development, sponsored by Shirley Ryan AbilityLab.
NCT06970522 is a study of Neuromuscular Disorders and Motor Development that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 40 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06970522, a study of Neuromuscular Disorders and Motor Development, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to see if wearable sensor technology can be used to evaluate muscle activity and/or identify atypical muscle tone in infants up to 48 weeks postmenstrual age (8 weeks corrected age). These sensors are placed on the surface of the skin and record data about a child's body movements and muscle activity.
Primary Outcome
Correlation of EMG sensor data and Hammersmith Neonatal Neurological Exam (HNNE) short form score, assessed before 8 weeks corrected age.
Conditions Studied
Study Locations (2)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2026-05-31 |
What NCT06970522 shows while recruiting
NCT06970522 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 3 conditions, with Neuromuscular Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT06970522 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06970522 about?
NCT06970522 is a clinical study titled "Wearable Sensors to Detect Atypical Muscle Activation in Young Infants". The purpose of this study is to see if wearable sensor technology can be used to evaluate muscle activity and/or identify atypical muscle tone in infants up to 48 weeks postmenstrual age (8 weeks corrected age). These sensors are placed on the surface of the skin and record data about a child's body...
What is the current status of trial NCT06970522?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-06-25. Estimated completion is 2026-05-31.
What conditions does trial NCT06970522 study?
This clinical trial studies the following conditions: Neuromuscular Disorders, Motor Development, Muscle Tone.
Who is sponsoring clinical trial NCT06970522?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06970522 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI